1. Academic Validation
  2. CA-074Me protection against anthrax lethal toxin

CA-074Me protection against anthrax lethal toxin

  • Infect Immun. 2009 Oct;77(10):4327-36. doi: 10.1128/IAI.00730-09.
Zachary L Newman 1 Stephen H Leppla Mahtab Moayeri
Affiliations

Affiliation

  • 1 Bacterial Toxins and Therapeutics Section, Laboratory of Bacterial Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
Abstract

Anthrax lethal toxin (LT) activates the NLRP1b (NALP1b) inflammasome and Caspase-1 in macrophages from certain inbred mouse strains, but the mechanism by which this occurs is poorly understood. We report here that similar to several NLRP3 (NALP3, cryopyrin)-activating stimuli, LT activation of the NLRP1b inflammasome involves lysosomal membrane permeabilization (LMP) and subsequent cytoplasmic Cathepsin B activity. CA-074Me, a potent Cathepsin B Inhibitor, protects LT-sensitive macrophages from cell death and prevents the activation of Caspase-1. RNA interference knockdown of Cathepsin B expression, however, cannot prevent LT-mediated cell death, suggesting that CA-074Me may also act on other cellular proteases released during LMP. CA-074Me appears to function downstream of LT translocation to the cytosol (as assessed by mitogen-activated protein kinase kinase cleavage), K(+) effluxes, and Proteasome activity. The initial increase in cytoplasmic activity of Cathepsin B occurs at the same time or shortly before Caspase-1 activation but precedes a larger-scale lysosomal destabilization correlated closely with cytolysis. We present results suggesting that LMP may be involved in the activation of the NLRP1b inflammasome.

Figures
Products